FDA Inspection 1166027 — Secura Bio, Inc
The FDA completed an inspection of Secura Bio, Inc on Mar 17, 2022 in Berkeley Heights, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 17, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berkeley Heights, NJ (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)